Table 2.
Variables Dichotomized by Lung Dose Level Groups
| Variable | Level | Lung dose level | Exact Chi-squre Test | |
|---|---|---|---|---|
| >=800 | < 800 | |||
| MRD levels | ||||
| MRD < 0.01% | 37 (61.67%) | 23 (38.33%) | 1.0000 | |
| MRD >= 0.01% | 13 (65.00%) | 7 (35.00%) | ||
| MRD levels | ||||
| MRD < 0.1% | 49 (59.76%) | 33 (40.24%) | 0.5557 | |
| MRD >= 0.1% | 10 (71.43%) | 4 (28.57%) | ||
| MRD levels | ||||
| Negative | 37 (61.67%) | 23 (38.33%) | 0.5016 | |
| Positive, 0.1%+ | 10 (71.43%) | 4 (28.57%) | ||
| Positive, <0.1% | 2 (40.00%) | 3 (60.00%) | ||
| Risk groups | ||||
| HR_CR2 | 39 (61.90%) | 24 (38.10%) | 0.3059 | |
| IR_CR2 | 8 (42.11%) | 11 (57.89%) | ||
| VHR_CR1 | 27 (60.00%) | 18 (40.00%) | ||
| Donor | ||||
| Matched | 40 (58.82%) | 28 (41.18%) | 1.0000 | |
| Other | 34 (57.63%) | 25 (42.37%) | ||
| Risk and Donor | ||||
| HR_CR2 Cord | 9 (42.86%) | 12 (57.14%) | 0.1966 | |
| HR_CR2 Matched | 17 (73.91%) | 6 (26.09%) | ||
| HR_CR2 Other | 13 (68.42%) | 6 (31.58%) | ||
| IR_CR2 Matched | 8 (42.11%) | 11 (57.89%) | ||
| VHR_CR1 Matched | 15 (57.69%) | 11 (42.31%) | ||
| VHR_CR1 Other | 12 (63.16%) | 7 (36.84%) | ||
| Treatment | ||||
| TacroMTX | 32 (49.23%) | 33 (50.77%) | 0.0475 | |
| TacroMTX Siroli | 42 (67.74%) | 20 (32.26%) | ||
| FieldName | ||||
| AP | 33 (41.25%) | 47 (58.75%) | 0.0000 | |
| RLAT | 41 (87.23%) | 6 (12.77%) | ||
| Position | ||||
| Decubitus | 14 (77.78%) | 4 (22.22%) | 0.0005 | |
| Seated | 22 (73.33%) | 8 (26.67%) | ||
| Standing | 7 (25.93%) | 20 (74.07%) | ||
| Supine | 30 (58.82%) | 21 (41.18%) | ||
Abbreviations: HR- high risk; CR-complete remission; VHR-very high risk; aGVHD-acute graft versus host disease; VOD-veno-occlusive disease; MRD-minimal residual disease; TRM-transplant-related mortality, TBI-total body irradiation;
*
Exact Chi-square Test.